2
Clinical Trials associated with CTL (cytotoxic lymphocyte)(Shandong Sunstem Biotechnology) / Unknown statusPhase 1/2IIT Phase I/II Study of DC Vaccine Targeting MG-7 Antigen to Treat Gastric Cancer
The primary purpose of the study is to determine the safety and efficacy of autologous DC vaccine in patients with later stage of gastric cancer. The DC vaccine is gene modified with gastric cancer specific antigen MG-7.
/ Active, not recruitingPhase 1IIT Phase 1 Study of CEA Specific Cytotoxic T Lymphocytes Induced by Dendritic Cells Infected by Recombinant Adeno-associated Virus With CEA Gene in Stage IV Gastric Cancer
The purpose of this study is to evaluate the clinical safety and preliminary efficacy of CEA specific cytotoxic T lymphocytes induced by dendritic cells infected by recombinant adeno-associated virus with CEA gene in the treatment of stage IV gastric cancer patients.
Start Date01 Jan 2016 |
Sponsor / Collaborator- |
100 Clinical Results associated with CTL (cytotoxic lymphocyte)(Shandong Sunstem Biotechnology)
100 Translational Medicine associated with CTL (cytotoxic lymphocyte)(Shandong Sunstem Biotechnology)
100 Patents (Medical) associated with CTL (cytotoxic lymphocyte)(Shandong Sunstem Biotechnology)
100 Deals associated with CTL (cytotoxic lymphocyte)(Shandong Sunstem Biotechnology)